Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
4scar19 (1 trial)
Leukemia (Phase 1)
Leukemia, B-Cell (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)
Trials (1 total)
Trial APIs (1 total)